Lilly combo therapy succeeds in lung cancer study
Eli Lilly and Co.’s combination cancer treatment met the main goal of a late-stage clinical trial in testing on patients with a form of lung cancer, the drugmaker announced.
About Reuters Health
This author has yet to write their bio.Meanwhile lets just say that we are proud Reuters Health contributed a whooping 3962 entries.
Entries by Reuters Health
FDA approves Pfizer’s biosimilar to Roche’s Herceptin
The U.S. Food and Drug Administration approved Pfizer Inc.’s biosimilar to Roche AG’s blockbuster breast cancer treatment Herceptin.
Regeneron/Sanofi wins U.S. approval for expanded use of skin drug
The U.S. Food and Drug Administration approved expanded use of Regeneron Pharmaceuticals Inc. and Sanofi SA’s eczema drug Dupixent to include patients aged between 12 and 17 years.
World must prepare for inevitable next flu pandemic, WHO says
The world will inevitably face another pandemic of flu and needs to prepare for the potential devastation that could cause, and not underestimate the risks, the World Health Organization (WHO) said.
Integra gets FDA warning letter for Boston plant
Integra Lifesciences Holdings Corp. received a warning letter from the U.S. Food and Drug Administration regarding the medical device maker ‘s manufacturing facility in Boston.
Mumps, other outbreaks force U.S. detention centers to quarantine over 2,000 migrants
The number of people amassed in immigration detention under the Trump administration has reached record highs, raising concerns among migrant advocates about disease outbreaks and resulting quarantines that limit access to legal services.
Companies lose bid to delay opioid epidemic trial
OxyContin manufacturer Purdue Pharma and two other drugmakers lost a bid to delay a landmark trial set for May 2019 in a multibillion-dollar lawsuit by Oklahoma’s attorney general accusing them of helping fuel an opioid abuse and overdose epidemic in the state.
EC approves Roche’s Tecentriq combo vs. lung cancer
Roche received European Commission (EC) approval for the company’s Tecentriq drug in combination with Avastin and chemo as an initial treatment for people with a specific type of lung cancer.
Knee surgery for torn cartilage may not be worthwhile
Many middle-aged and older adults with torn cartilage and pain in their knee are not likely to benefit from so-called arthroscopic surgery, a review of past studies suggests.
Beer first or wine, either way might not be fine
The old adage that drinking beer before wine prevents hangovers turns out to be a myth, German researchers say.
